Aller au contenu

Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results.

Nom du journal : Leukemia

Année : 2024

Volume : 38

Page de départ : 1522-1533

Auteurs: Cortes, JE, Sasaki, K, Kim, DW, Hughes, TP, Etienne, G, Mauro, MJ & al,